Metropolis Healthcare Limited
Healthcare›Healthcare›Healthcare Services›Healthcare Service Provider
Key metrics
Price as of 2026-07-16
Stock price
₹578.45
Market cap
11,993 Cr
Stock P/E
63.8
P/B
7.87
Dividend yield
0.2%
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 277 Cr | 586 Cr | 877 Cr | 1,208 Cr | 313 Cr | 663 Cr | 323 Cr | 345 Cr | 386 Cr | 429 Cr | 406 Cr | 425 Cr |
| Operating expenses (approx.) | 211 Cr | 444 Cr | 668 Cr | 916 Cr | 232 Cr | 489 Cr | 248 Cr | 276 Cr | 289 Cr | 320 Cr | 311 Cr | 308 Cr |
| EBITDA | 66 Cr | 142 Cr | 209 Cr | 292 Cr | 81 Cr | 174 Cr | 75 Cr | 69 Cr | 97 Cr | 109 Cr | 95 Cr | 116 Cr |
| OPM % | 23.8% | 24.3% | 23.9% | 24.2% | 25.9% | 26.3% | 23.1% | 20.1% | 25.2% | 25.4% | 23.3% | 27.4% |
| Other income | 3 Cr | 4 Cr | 7 Cr | 9 Cr | 2 Cr | 6 Cr | 3 Cr | 7 Cr | 8 Cr | 0.89 Cr | 9 Cr | 8 Cr |
| Interest | 6 Cr | 12 Cr | 17 Cr | 23 Cr | 5 Cr | 9 Cr | 5 Cr | 5 Cr | 5 Cr | 6 Cr | 6 Cr | 8 Cr |
| Depreciation | 21 Cr | 43 Cr | 68 Cr | 94 Cr | 26 Cr | 52 Cr | 28 Cr | 29 Cr | 31 Cr | 32 Cr | 32 Cr | 39 Cr |
| Profit before tax | 39 Cr | 87 Cr | 124 Cr | 175 Cr | 51 Cr | 112 Cr | 42 Cr | 36 Cr | 61 Cr | 71 Cr | 57 Cr | 70 Cr |
| Tax % | 26.1% | 26.0% | 26.0% | 26.5% | 25.4% | 24.6% | 25.7% | 18.9% | 26.1% | 25.5% | 26.4% | 27.0% |
| Net profit | 29 Cr | 65 Cr | 92 Cr | 128 Cr | 38 Cr | 85 Cr | 31 Cr | 29 Cr | 45 Cr | 53 Cr | 42 Cr | 51 Cr |
| EPS (₹) | ₹5.62 | ₹12.55 | ₹17.85 | ₹24.95 | ₹7.41 | ₹16.49 | ₹6.11 | ₹5.69 | ₹8.70 | ₹10.17 | ₹7.99 | ₹2.46 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2019Standalone only | Mar 2020Standalone only | Mar 2021Standalone only | Mar 2022Standalone only | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 761 Cr | 856 Cr | 998 Cr | 1,228 Cr | 1,148 Cr | 1,208 Cr | 1,331 Cr | 1,646 Cr | Sign in for TTM |
| Operating expenses (approx.) | 554 Cr | 640 Cr | 700 Cr | 852 Cr | 860 Cr | 925 Cr | 1,013 Cr | 1,228 Cr | Sign in for TTM |
| EBITDA | 207 Cr | 217 Cr | 298 Cr | 376 Cr | 288 Cr | 283 Cr | 318 Cr | 417 Cr | Sign in for TTM |
| OPM % | 27.2% | 25.3% | 29.9% | 30.6% | 25.1% | 23.4% | 23.9% | 25.4% | Sign in for TTM |
| Other income | 8 Cr | 9 Cr | 12 Cr | 18 Cr | 15 Cr | 9 Cr | 15 Cr | 26 Cr | Sign in for TTM |
| Interest | 0.53 Cr | 8 Cr | 8 Cr | 20 Cr | 27 Cr | 23 Cr | 19 Cr | 25 Cr | Sign in for TTM |
| Depreciation | 20 Cr | 39 Cr | 46 Cr | 63 Cr | 89 Cr | 94 Cr | 109 Cr | 134 Cr | Sign in for TTM |
| Profit before tax | 187 Cr | 169 Cr | 244 Cr | 293 Cr | 188 Cr | 175 Cr | 191 Cr | 259 Cr | Sign in for TTM |
| Tax % | 33.7% | 24.3% | 25.0% | 26.8% | 23.5% | 26.5% | 23.8% | 26.2% | Sign in for TTM |
| Net profit | 124 Cr | 128 Cr | 183 Cr | 215 Cr | 143 Cr | 128 Cr | 146 Cr | 191 Cr | Sign in for TTM |
| EPS (₹) | ₹24.06 | ₹25.36 | ₹35.97 | ₹41.87 | ₹27.91 | ₹24.95 | ₹28.29 | ₹9.19 | Sign in for TTM |
| Dividend payout % | — | — | — | 19.1% | 28.6% | 16.0% | 12.7% | 10.8% | Sign in for TTM |
Sign in for TTM
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2019Standalone only | Mar 2020Standalone only | Mar 2021Standalone only | Mar 2022Standalone only | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 10 Cr | 10 Cr | 10 Cr | 10 Cr | 10 Cr | 10 Cr | 10 Cr | 41 Cr |
| Reserves | 420 Cr | 525 Cr | 698 Cr | 876 Cr | 980 Cr | 1,086 Cr | 1,321 Cr | 1,472 Cr |
| Borrowings | 17 Cr | — | — | 259 Cr | 79 Cr | — | 9 Cr | 19 Cr |
| Other liabilities | 95 Cr | 176 Cr | 225 Cr | 262 Cr | 432 Cr | 456 Cr | 524 Cr | 595 Cr |
| Total liabilities | 528 Cr | 688 Cr | 933 Cr | 1,345 Cr | 1,502 Cr | 1,555 Cr | 1,867 Cr | 2,138 Cr |
| Fixed assets (net) | 96 Cr | 97 Cr | 93 Cr | 118 Cr | 137 Cr | 156 Cr | 190 Cr | 215 Cr |
| CWIP | 6 Cr | 3 Cr | 0.0000 Cr | 0.0000 Cr | 0.0000 Cr | 0.0000 Cr | 0.0000 Cr | 0.0000 Cr |
| Investments | 135 Cr | 130 Cr | 131 Cr | 649 Cr | 15 Cr | 55 Cr | 71 Cr | 142 Cr |
| Other assets | 229 Cr | 322 Cr | 528 Cr | 350 Cr | 303 Cr | 316 Cr | 346 Cr | 469 Cr |
| Total assets | 528 Cr | 688 Cr | 933 Cr | 1,345 Cr | 1,502 Cr | 1,555 Cr | 1,867 Cr | 2,138 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2019Standalone only | Mar 2020Standalone only | Mar 2021Standalone only | Mar 2022Standalone only | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | — | — | — | 253 Cr | 247 Cr | 264 Cr | 263 Cr | 351 Cr |
| Cash from investing | — | — | — | -735 Cr | 47 Cr | -89 Cr | -201 Cr | -223 Cr |
| Cash from financing | — | — | — | 163 Cr | -292 Cr | -181 Cr | -87 Cr | -115 Cr |
| Net cash flow | — | — | — | -319 Cr | 2 Cr | -7 Cr | -25 Cr | 12 Cr |
| Free cash flow (OCF − Capex) | — | — | — | 223 Cr | 194 Cr | 200 Cr | 219 Cr | 307 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2019Standalone only | Mar 2020Standalone only | Mar 2021Standalone only | Mar 2022Standalone only | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| ROCE % | 43.5% | 33.2% | 35.6% | 35.3% | 18.6% | 17.1% | 15.6% | 18.4% |
| ROE % | 27.9% | 23.8% | 25.9% | 24.2% | 14.4% | 11.6% | 10.9% | 12.5% |
| Debtor days | 74 | 68 | 55 | 44 | 39 | 38 | — | — |
| Inventory days | 51 | 38 | 57 | 65 | 64 | 58 | 65 | 51 |
| Days payable | 94 | 155 | 154 | 124 | 135 | 150 | — | — |
| Cash conversion cycle | 31 | -48 | -42 | -15 | -32 | -53 | 65 | 51 |
| Debt / equity | 0.04 | — | 0.00 | 0.31 | 0.08 | — | 0.0067 | 0.01 |
| Current ratio | 2.01 | 2.26 | 3.27 | 1.24 | 1.14 | 1.28 | 1.18 | 1.40 |
| Net debt / EBITDA | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | -0.22 | -0.10 | -0.09 |
Compare with peers
Loading peers…